Berkeley, CA, United States of America

Arthur Karler

This inventor holds 1 USPTO granted patent. Top assignee: Diagnostic Data, Inc.. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur Karler. Retrieved from https://idiyas.com/inventor/arthur-karler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur Karler: Innovator in Arthritis Treatment

Introduction

Arthur Karler is a notable inventor based in Berkeley, California. He has made significant contributions to the field of medicine, particularly in the treatment of arthritis and related conditions. His innovative approach has garnered attention for its effectiveness and minimal side effects.

Latest Patents

Arthur Karler holds a patent for the treatment of arthritis and allied conditions using xenylsalate. The patent describes the use of xenylsalate hydrochloride, which can be administered systemically, either orally or subcutaneously. This method has been found to provide effective relief for the symptoms of arthritis, with substantially no side effects reported.

Career Highlights

Karler's career is marked by his dedication to improving patient outcomes through innovative treatments. He has worked with Diagnostic Data, Inc., where he has been able to apply his research and findings in a practical setting. His work has contributed to advancements in the medical field, particularly in pain management for arthritis sufferers.

Conclusion

Arthur Karler's contributions to the treatment of arthritis through his patented method highlight his role as an important inventor in the medical field. His innovative approach continues to impact the lives of those suffering from arthritis and allied conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…